Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/20/2025

Medication Options for Insomnia in Patients on Stimulants and Antidepressants

First-Line Medication Options

  • The American Academy of Sleep Medicine recommends zolpidem 10mg for both sleep onset and maintenance insomnia, with a short to intermediate duration of action that minimizes morning residual effects 1, 3
  • Eszopiclone 2-3mg is another excellent option with intermediate action and no short-term usage restrictions, as suggested by the American Academy of Sleep Medicine 1, 2
  • Zaleplon 10mg may be particularly useful if the insomnia primarily affects sleep onset rather than maintenance, according to the American Academy of Sleep Medicine 2

Timing Considerations

  • The American Academy of Sleep Medicine advises morning dosing of stimulants to minimize insomnia exacerbation 3
  • Administration of sleep medications on an empty stomach is recommended by the American Academy of Sleep Medicine to maximize effectiveness 4
  • The American Academy of Sleep Medicine suggests using BzRAs at the lowest effective dose and for the shortest duration necessary 3

Alternative Medication Options

  • Ramelteon 8mg (melatonin receptor agonist) is a non-scheduled alternative primarily for sleep-onset insomnia with minimal side effects, as reported by the American Academy of Sleep Medicine 4
  • Low-dose doxepin (3-6mg) can be considered if BzRAs are ineffective or poorly tolerated, according to the American Academy of Sleep Medicine 3

Special Considerations for This Patient

  • The American Academy of Sleep Medicine recommends avoiding sedating antidepressants like trazodone or mirtazapine as they may interact with the patient's current antidepressant 2, 4

Monitoring and Follow-up

  • The American Academy of Sleep Medicine suggests tracking sleep patterns with sleep logs to evaluate treatment efficacy 3
  • Assessing for adverse effects including complex sleep behaviors (sleepwalking, sleep-eating, sleep-driving) is recommended by the American Academy of Sleep Medicine 4
  • Considering tapering sleep medication after 3-4 weeks if insomnia improves is advised by the American Academy of Sleep Medicine 3

Important Cautions

  • The American Academy of Sleep Medicine warns against combining BzRAs with alcohol or other CNS depressants 4
  • BzRAs may cause next-morning impairment, particularly at higher doses, as reported by the National Comprehensive Cancer Network 5
  • Over-the-counter antihistamines and herbal supplements like melatonin, valerian, or L-tryptophan have limited evidence for efficacy and are not recommended by the American Academy of Sleep Medicine 6, 3

REFERENCES

1

clinical guideline for the evaluation and management of chronic insomnia in adults. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008

2

Medication Management for Insomnia and Anxiety in Patients with Multiple Conditions [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

clinical guideline for the evaluation and management of chronic insomnia in adults. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008

4

clinical guideline for the evaluation and management of chronic insomnia in adults. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008

5

palliative care version 1.2016. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

6

clinical guideline for the evaluation and management of chronic insomnia in adults. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008